{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:15Z","timestamp":1793144055786,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120603","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T09:44:52Z","timestamp":1757843092000},"page":"120603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Insights into the stability of serum calcitonin and a comparison of three serum calcitonin immunoassays"],"prefix":"10.1016","volume":"579","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9134-7395","authenticated-orcid":false,"given":"Amber","family":"Mater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Boelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke C.","family":"Heijboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-0301","authenticated-orcid":false,"given":"Jacquelien J.","family":"Hillebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cca.2025.120603_b0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","article-title":"Cancer Incidence and Survival Trends by Subtype using Data from the Surveillance Epidemiology and end results program, 1992-2013","volume":"26","author":"Noone","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2025.120603_b0010","unstructured":"American Cancer Society I. Thyroid Cancer Survival Rates, by Type and Stage 2024 [updated 23-08-2023. Available from: https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"issue":"8","key":"10.1016\/j.cca.2025.120603_b0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/a-1145-8479","article-title":"Update on the Treatment of Medullary Thyroid Carcinoma in patients with Multiple Endocrine Neoplasia Type 2","volume":"52","author":"Ilanchezhian","year":"2020","journal-title":"Horm. Metab. Res."},{"issue":"996","key":"10.1016\/j.cca.2025.120603_b0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1098\/rspb.1966.0044","article-title":"The cytochemistry of the thyroid C cells and their relationship to calcitonin","volume":"164","author":"Pearse","year":"1966","journal-title":"Proc. R. Soc. Lond. B"},{"issue":"5","key":"10.1016\/j.cca.2025.120603_b0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/endo-70-5-638","article-title":"Evidence for Calcitonin\u2014A New Hormone from the Parathyroid that Lowers Blood Calcium","volume":"70","author":"Copp","year":"1962","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2025.120603_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0083-6729(08)60682-2","article-title":"Cellular and molecular mechanisms in the regulation and function of osteoclasts","volume":"46","author":"Chambers","year":"1991","journal-title":"Vitam. Horm."},{"issue":"5689","key":"10.1016\/j.cca.2025.120603_b0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bmj.1.5689.135","article-title":"Renal effects of calcitonin","volume":"1","author":"Cochran","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cca.2025.120603_b0040","doi-asserted-by":"crossref","unstructured":"C. Durante, L. Heged\u00fcs, A. Czarniecka, R. Paschke, G. Russ, F. Schmitt, et al., 2023 European Thyroid Association Clinical Practice guidelines for thyroid nodule management, Eur Thyroid J. 12 (5) e230067 (2023).","DOI":"10.1530\/ETJ-23-0067"},{"issue":"3","key":"10.1016\/j.cca.2025.120603_b0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.30360","article-title":"2015 American Thyroid Association Management guidelines for Adult patients with Thyroid Nodules and Differentiated Thyroid Cancer: what is new and what has changed?","volume":"123","author":"Haugen","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.cca.2025.120603_b0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.cca.2025.120603_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40618-020-01356-9","article-title":"Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment","volume":"44","author":"Fugazzola","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cca.2025.120603_b0060","unstructured":"Schildkliercarcinoom [Internet]. 2024 [cited 30-09-2024]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/schildkliercarcinoom_2024\/startpagina_-_schildkliercarcinoom_2024.html."},{"issue":"1","key":"10.1016\/j.cca.2025.120603_b0065","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-24-0156","article-title":"Thyroglobulin and calcitonin measurements: pitfalls and future perspectives","volume":"264","author":"Mater","year":"2024","journal-title":"J Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2025.120603_b0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1373\/clinchem.2010.151688","article-title":"Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in patients with and without Medullary Thyroid Cancer","volume":"57","author":"Kratzsch","year":"2011","journal-title":"Clinical Chemistry."},{"issue":"2","key":"10.1016\/j.cca.2025.120603_b0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/CCLM.2011.036","article-title":"Analytical validation of the Liaison Calcitonin_II-gen (DiaSorin)","volume":"49","author":"Cavalier","year":"2011","journal-title":"Clinical Chemistry and Laboratory Medicine."},{"issue":"2","key":"10.1016\/j.cca.2025.120603_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinchem\/36.2.381","article-title":"Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma","volume":"36","author":"Perdrisot","year":"1990","journal-title":"Clin Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120603_b0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0196-9781(94)00177-4","article-title":"Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin","volume":"16","author":"Wimalawansa","year":"1995","journal-title":"Peptides."},{"issue":"10","key":"10.1016\/j.cca.2025.120603_b0090","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","article-title":"Reference Intervals for Serum Calcitonin in men, Women, and Children","volume":"50","author":"Basuyau","year":"2004","journal-title":"Clinical Chemistry."},{"key":"10.1016\/j.cca.2025.120603_b0095","unstructured":"Aarsand AK WC, Fernandez-Calle P, Jonker N, Diaz-Garzon J, Coskun A, Sufrate B, Parillo IM, Galior K, Topcu D, Gonzales-Lao E, Carobene A, Bartlett WA, Sandberg S. The EFLM Biological Variation Database [updated 19-02-2025. Available from: The EFLM Biological Variation Database. https:\/\/biologicalvariation.eu\/ [cited 6\/6\/2025]."},{"issue":"4","key":"10.1016\/j.cca.2025.120603_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/cclm-2020-1885","article-title":"European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants","volume":"60","author":"Bottani","year":"2022","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)."},{"issue":"12","key":"10.1016\/j.cca.2025.120603_b0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clinbiochem.2016.05.006","article-title":"Performance evaluation of an automated electrochemiluminescent calcitonin (CT) immunoassay in diagnosis of medullary thyroid carcinoma","volume":"49","author":"Schiettecatte","year":"2016","journal-title":"Clin Biochem."},{"issue":"12","key":"10.1016\/j.cca.2025.120603_b0110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0026-0495(77)90030-0","article-title":"Degradation of human calcitonin in human plasma","volume":"26","author":"Baylin","year":"1977","journal-title":"Metabolism."},{"issue":"3","key":"10.1016\/j.cca.2025.120603_b0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/00045632231160371","article-title":"Stability assessment of serum tumour markers: Calcitonin, chromogranin a, thyroglobulin and anti-thyroglobulin antibodies","volume":"60","author":"Thirkettle","year":"2023","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.cca.2025.120603_b0120","doi-asserted-by":"crossref","unstructured":"J. Zhou, A. Fabros, S.J. Lam, A. Coro, R. Selvaratnam, D. Brinc, et al., The stability of 65 biochemistry analytes in plasma, serum, and whole blood, Clinical Chemistry and Laboratory Medicine (CCLM) 62 (8) (2024) 1557\u20131569.","DOI":"10.1515\/cclm-2023-1192"},{"issue":"2","key":"10.1016\/j.cca.2025.120603_b0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jalm\/jfab162","article-title":"Analytical Performance Evaluation of a New Calcitonin Assay","volume":"7","author":"Moretti","year":"2022","journal-title":"J Appl Lab Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120603_b0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.47429\/lmo.2021.11.4.235","article-title":"Comparison of three Automated Calcitonin Immunoassays for evaluating the Equivalence Near the Clinical Decision Point","volume":"11","author":"Song","year":"2021","journal-title":"Lab Med Online."},{"issue":"3","key":"10.1016\/j.cca.2025.120603_b0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2478\/rrlm-2021-0024","article-title":"Correction factor between two calcitonin assays: DiaSorin LiaisonXL and Cobas E601","volume":"29","author":"Baetu","year":"2021","journal-title":"Revista Romana De Medicina De Laborator."},{"issue":"5","key":"10.1016\/j.cca.2025.120603_b0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/cclm-2011-0920","article-title":"Thyroid volume influences serum calcitonin levels in a thyroid-healthy population: results of a 3-assay, 519 subjects study","volume":"50","author":"Giovanella","year":"2012","journal-title":"Clinical Chemistry and Laboratory Medicine."},{"issue":"5","key":"10.1016\/j.cca.2025.120603_b0145","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1515\/CCLM.2007.124","article-title":"Measurement of calcitonin by immunoassay analyzers","volume":"45","author":"Bieglmayer","year":"2007","journal-title":"Clin Chem Lab Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120603_b0150","article-title":"The Prognostic and Biological significance of Cellular Heterogeneity in Medullary Thyroid Carcinoma: a Study of Calcitonin, L-Dopa Decarboxylase, and Histaminase","volume":"54","author":"Lipmann","year":"1982","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"key":"10.1016\/j.cca.2025.120603_b0155","article-title":"Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules","volume":"3(3):Cd010159","author":"Verbeek","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"9","key":"10.1016\/j.cca.2025.120603_b0165","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1515\/cclm-2021-0361","article-title":"Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma","volume":"59","author":"Giovanella","year":"2021","journal-title":"Clin Chem Lab Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120603_b0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.15287","article-title":"Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: a Two-step Approach","volume":"103","author":"Clausi","year":"2025","journal-title":"Clin Endocrinol (oxf)"},{"issue":"9","key":"10.1016\/j.cca.2025.120603_b0175","first-page":"1030","article-title":"Progastrin-Releasing Peptide and Procalcitonin as Additional Markers in the Diagnostic Workup for Medullary Thyroid Carcinoma","volume":"35","author":"Schonebaum","year":"2025","journal-title":"Thyroid\u00ae"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:39:49Z","timestamp":1766511589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125004826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S0009898125004826"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120603","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the stability of serum calcitonin and a comparison of three serum calcitonin immunoassays","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120603"}}